Deep Genomics sets up shop to marry deep learning and genomics

Deep Genomics has opened its doors. The University of Toronto spinout is working to explore the potential of applying deep learning to genomics, first as a way to improve genetic testing. The early focus on genetic testing is a way for Deep Genomics to get started quickly, but in the longer term the plan is to apply the approach to drug development and personalized medicine. "We envision a future where computers are trusted to predict the outcome of laboratory experiments and treatments, long before anyone picks up a test tube," Deep Genomics CEO Brendan Frey told Kurzweil Accelerating Intelligence. Article | More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.